{
  "id": "GELF_criteria.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-07-16",
      "name": "Therese Lindbergq",
      "organisation": "Cambio CDS",
      "email": "therese.lindberg@cambio.se"
    },
    "lifecycle_state": "Initial",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To determine if immediate therapy for follicular lymphoma is required.",
        "keywords": [
          "GELF",
          "criteria",
          "groupe d'etude",
          "lymphomes folliculaires",
          "tumor",
          "cytopenia",
          "compression"
        ],
        "use": "Patients must meet ≥1 criteria to be considered “high” tumor burden; criteria below:\n- Any nodal or extranodal tumor mass >7 cm diameter\n- Involvement of at least 3 nodal sites, each with diameter >3 cm\n- Presence of any systemic or B symptoms\n- Splenic enlargement with inferior margin below the umbilical line\n- Compression syndrome (ureteral, orbital, gastrointestinal)\n- Pleural or peritoneal serous effusion (irrespective of cell content)\n- Leukemic phase (>5.0 x109/L circulating malignant cells)\n- Cytopenia (granulocyte count < 1.0 x109/L and/or platelets < 100x109/L)",
        "copyright": "@CambioCDS"
      }
    },
    "other_details": {
      "references": "1. Brice P, Bastion Y, Lepage E, et al. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. J Clin Oncol. 1997. 15:1110-7."
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-EVALUATION.gelf_criteria.v0",
        "template_id": "openEHR-EHR-EVALUATION.gelf_criteria.v0",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/items[at0005]"
          },
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/items[at0006]"
          },
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/items[at0010]"
          },
          "gt0006": {
            "id": "gt0006",
            "path": "/data[at0001]/items[at0003]"
          },
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/items[at0004]"
          },
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/items[at0007]"
          },
          "gt0009": {
            "id": "gt0009",
            "path": "/data[at0001]/items[at0008]"
          },
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/items[at0009]"
          }
        }
      },
      "gt0011": {
        "id": "gt0011",
        "model_id": "openEHR-EHR-EVALUATION.gelf_criteria.v0",
        "template_id": "openEHR-EHR-EVALUATION.gelf_criteria.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0012": {
            "id": "gt0012",
            "path": "/data[at0001]/items[at0027]"
          },
          "gt0013": {
            "id": "gt0013",
            "path": "/data[at0001]/items[at0028]"
          }
        }
      }
    },
    "rules": {
      "gt0014": {
        "id": "gt0014",
        "priority": 2,
        "when": [
          "$gt0003|Presence of any systemic or B symptoms|!=null",
          "$gt0004|Splenic enlargement with inferior margin below the umbilical line|!=null",
          "$gt0005|Cytopenia (granulocyte count < 1.0x10⁹/L and/or platelets < 100x10⁹/L)|!=null",
          "$gt0006|Any nodal or extranodal tumor mass >7 cm diameter|!=null",
          "$gt0007|Involvement of at least 3 nodal sites, each with diameter >3 cm|!=null",
          "$gt0008|Compression syndrome (ureteral, orbital, gastrointestinal)|!=null",
          "$gt0009|Pleural or peritoneal serous effusion (irrespective of cell content)|!=null",
          "$gt0010|Leukemic phase (>5.0 x10⁹/L circulating malignant cells)|!=null"
        ],
        "then": [
          "$gt0012|GELF Criteria|.magnitude=$gt0003.value+$gt0004.value+$gt0005.value+$gt0006.value+$gt0007.value+$gt0008.value+$gt0009.value+$gt0010.value",
          "$gt0013|Comment|='Positive for GELF Criteria Immediate therapy is indicated. Note; When a patient has ≥1 criteria, this is considered “high” tumor burden.'"
        ]
      },
      "gt0015": {
        "id": "gt0015",
        "priority": 1,
        "when": [
          "$gt0012|GELF Criteria|==0"
        ],
        "then": [
          "$gt0013|Comment|='Negative for GELF Criteria Immediate therapy is NOT indicated.'"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "GELF criteria",
            "description": "Groupe d'Etude des Lymphomes Folliculaires (GELF) Criteria determines if immediate therapy for follicular lymphoma is required."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Presence of any systemic or B symptoms",
            "description": "*"
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Splenic enlargement with inferior margin below the umbilical line",
            "description": "*"
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Cytopenia (granulocyte count < 1.0x10⁹/L and/or platelets < 100x10⁹/L)",
            "description": "*"
          },
          "gt0006": {
            "id": "gt0006",
            "text": "Any nodal or extranodal tumor mass >7 cm diameter",
            "description": "*"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Involvement of at least 3 nodal sites, each with diameter >3 cm",
            "description": "View more nodal site information in the More Info section."
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Compression syndrome (ureteral, orbital, gastrointestinal)",
            "description": "*"
          },
          "gt0009": {
            "id": "gt0009",
            "text": "Pleural or peritoneal serous effusion (irrespective of cell content)",
            "description": "*"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Leukemic phase (>5.0 x10⁹/L circulating malignant cells)",
            "description": "*"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "GELF Criteria",
            "description": "*"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "Comment",
            "description": "*"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Calculate GELF critera"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "GELF critera = 0"
          }
        }
      }
    }
  }
}